leisure time -WSS

leisure time

author：leisure time 2025-09-28 21:07:00 - browse：219

Balance innovation — A federal judge made a key ruling in a lawsuit challenging a new drug pricing program Adobe

WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.

The case centers on Democrats’ new law, which empowered the Medicare program to start negotiating lower prices for certain medicines that are especially expensive for the government. Judge Michael Newman, a Trump appointee to the U.S. District Court for the Southern District of Ohio, ruled against the U.S. Chamber of Commerce, which had sued the federal government and asked for the program to be stopped while litigation continues.

Medicare officials announced the first 10 drugs they would negotiate over last month, and the deadline for the pharmaceutical companies to sign agreements to start bargaining is Oct. 1. The Chamber of Commerce had requested a decision on the preliminary injunction by that date.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Flash flood warnings continue for parts of Missouri, Illinois

focus

WSS

Argenx drug significantly slows progression of nerve disorder

J&J expands global access to TB drug amid advocacy campaign

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Involuntary treatment for addiction doesn't work

Congress: Eradicate hepatitis C and reduce the deficit

Sage considers ways to reduce costs following FDA rejection

focus

leisure time

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

J&J expands global access to TB drug amid advocacy campaign

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Election results set back Medicaid expansion plans

23andMe had bad news about my health. I wish a person had delivered it

Flash flood warnings continue for parts of Missouri, Illinois

BioMarin wins approval for gene therapy to treat hemophilia A

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The new HIV moral panic

knowledge

Failure, not just success, should guide future doctors

Failure, not just success, should guide future doctors

Federal judge rules Oregon’s tough new gun law is constitutional

Care demand spikes challenge UnitedHealth’s provider arm

Paxlovid rebound happens. Why and to whom are still a mystery

Google's generative AI to analyze medical images — and talk to docs

explore

hotspot

focus

focus